Aduhelm (aducanumab) is an intravenously administered amyloid beta-directed antibody for the treatment of Alzheimer disease.
If you have a Hayes login, click here to view the full report on the Knowledge Center.
Aduhelm (aducanumab) is an intravenously administered amyloid beta-directed antibody for the treatment of Alzheimer disease.
If you have a Hayes login, click here to view the full report on the Knowledge Center.